Hostname: page-component-78c5997874-s2hrs Total loading time: 0 Render date: 2024-11-10T05:17:57.212Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical perspective: Linking psychosocial care to the disease continuum in patients with multiple myeloma*

Published online by Cambridge University Press:  24 June 2014

James Zabora ,
Joanne Buzaglo ,
Vicki Kennedy ,
Tiffany Richards ,
Tara Schapmire ,
Brad Zebrack  and
Irene M. Ghobrial
James Zabora*
Affiliation:
Life with Cancer, Inova Health System, Fairfax, Virginia
Joanne Buzaglo
Affiliation:
Cancer Support Community, Washington, DC
Vicki Kennedy
Affiliation:
Cancer Support Community, Washington, DC
Tiffany Richards
Affiliation:
MD Anderson Cancer Center, Houston, Texas
Tara Schapmire
Affiliation:
University of Louisville School of Medicine, Louisville, Kentucky
Brad Zebrack
Affiliation:
University of Michigan School of Social Work, Ann Arbor, Michigan
Irene M. Ghobrial
Affiliation:
Dana–Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts
*
Address correspondence and reprint requests to: James Zabora, Life with Cancer, Inova Health System, 8110 Gatehouse Road, Fairfax, Virginia. E-mail: James.Zabora@inova.org
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

A model of psychosocial care specific for patients with multiple myeloma and their caregivers has not yet been proposed. We sought to develop a model of care that considers the specific profile of this disease.

Method:

The authors, representing a multidisciplinary care team, met in December of 2012 to identify a model of psychosocial care for patients with multiple myeloma and their caregivers. This model was determined by consensus during the meeting and via total agreement following the meeting. The meeting was sponsored by Onyx Pharmaceuticals.

Results:

The need for targeted psychosocial care for the multiple myeloma patient and caregiver throughout the disease process is essential to ensure quality of life and optimal treatment outcomes. We propose herein the first known model of care for the treatment of multiple myeloma that engages both the patient and their caregivers.

Significance of results:

Innovative partnerships between psychosocial providers and other entities such as pharmaceutical companies can maximize resources for comprehensive program development. This manuscript proposes a model of care that promotes active engagement in therapies for multiple myeloma while engaging the individual patient and their family caregivers. This treatment approach must be evidence based in terms of distress screening tools, comprehensive psychosocial assessments, and, most importantly, in the interventions and measurements of response that clinicians apply to this population.

Keywords

Psychosocial careDistressMultiple myelomaStandard of care
Type
Original Articles
Information
Palliative & Supportive Care , Volume 13 , Issue 4 , August 2015 , pp. 829 - 838
Copyright
Copyright © Cambridge University Press 2014 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

*

This paper was developed in part following a roundtable meeting of the authors in Dallas, Texas on December 1, 2012.

References

REFERENCES

American College of Surgeons (2012). Cancer program standards 2012: Ensuring patient-centered care. Available at http://www.facs.org/cancer/coc/cps2012draft.pdf.Google Scholar
Anderson, B.L., Yang, H., Farrar, W.B., et al. (2008). Psychological intervention improves survival for breast cancer patients. Cancer, 113(12), 3450–3458.Google Scholar
Anderson, B.L., Thornton, L.M., Shapiro, C.L., et al. (2010). Biobehavioral, immune, and health benefits following recurrence for psychological intervention participants. Clinical Cancer Research, 16, 3270–3278.CrossRefGoogle Scholar
Bilotti, E., Faiman, B.M., Richards, T.A., et al. (2011). Survivorship care guidelines for patients living with multiple myeloma. Clinical Journal of Oncology Nursing, 15(4), 5–8.CrossRefGoogle ScholarPubMed
Broyl, A., Jongen, J.L. & Sonneveld, P. (2012). General aspects of mechanisms of peripheral neuropathy associated with bortezomib in patients with newly diagnosed multiple myeloma (review). Seminars in Hematology, 49(3), 249–257.CrossRefGoogle Scholar
Carlson, L.E., Angen, M., Cullum, J., et al. (2004). High levels of untreated distress and fatigue in cancer patients. British Journal of Cancer, 90(12), 2297–2304.Google Scholar
Coleman, E.A., Goodwin, J.A., Coon, S.K., et al. (2011). Fatigue, sleep, pain, mood, and performance status in patients with multiple myeloma. Cancer Nursing, 34(3), 219–227.CrossRefGoogle ScholarPubMed
Cwikel, J., Behar, L. & Rabson-Hare, J. (2000). A comparison of a vote count and a meta-analysis review of intervention research with adult cancer patients. Research on Social Work Practice, 10, 139–158.Google Scholar
DiMatteo, M.R. (2004). Variations in patients' adherence to medical recommendations: A quantitative review of 50 years of research. Medical Care, 42(3), 200–209.CrossRefGoogle ScholarPubMed
Faller, H., Schuler, M., Richard, M., et al. (2013). Effects of psycho-oncologic interventions on emotional distress and quality of life in adult patients with cancer: Systematic review and meta-analysis. Journal of Clinical Oncology. 31(6), 782–793.Google Scholar
Fawzy, F.I., Fawzy, N.W., Arndt, L.A., et al. (1995). Critical review of psychosocial interventions in cancer care. Archives of General Psychiatry. 52(2), 100–113.Google Scholar
Fobair, P. & Zabora, J.R. (1995). Family functioning as a resource variable. Journal of Psychosocial Oncology, 13(1/2), 97–114.Google Scholar
Forsyth, L.P., Kent, E.E., Weaver, K.E., et al. (2013). Receipt of psychosocial care among cancer survivors in the United States. Journal of Clinical Oncology, 31(16), 1961–1969.Google Scholar
Given, B., Given, C.W., Kozachik, S., et al. (2003). Family caregiving interventions in cancer care. In Evidence-based cancer care and prevention: Behavioral interventions. Given, C.W. (ed.), pp. 332–370. New York: Springer.Google Scholar
Gottlieb, B.H. & Wachala, E.D. (2007). Cancer support groups: A critical review of empirical studies. Psycho-Oncology, 16, 379–400.CrossRefGoogle ScholarPubMed
Graves, K. (2003). Social cognitive theory and cancer patients' quality of life: A meta-analysis of psychosocial intervention components. Health Psychology, 22, 210–219.Google Scholar
Houts, P.S., Nezu, A.M., Nezu, C.M., et al. (1996). The prepared family caregiver: A problem-solving approach to family caregiver education. Patient Education & Counseling, 27(1), 63–73.Google Scholar
Institute of Medicine (IOM) (2008). Cancer care for the whole patient: Meeting psychosocial health needs. Washington, DC: National Academies Press.Google Scholar
Irwin, K.E., Greer, J.A., Khatib, J., et al. (2012). Early palliative care and metastatic non-small-cell lung cancer: Potential mechanisms of prolonged survival. Chronic Respiratory Disease, 10(1), 35–47.Google Scholar
Jacobsen, P.B. (2008). Psychosocial interventions for anxiety and depression in adult cancer patients: Achievements and challenges. CA: A Cancer Journal for Clinicians, 58, 214.Google Scholar
Jones, D., Vichaya, E.G., Wang, X.S., et al. (2013). Acute cognitive impairment in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplant. Cancer, 119(23), 4188–4195.Google Scholar
Kurtin, S., Lilleby, K. & Spong, J. (2013). Caregivers of multiple myeloma survivors. Clinical Journal of Oncology Nursing, 17(1), 25–32.CrossRefGoogle ScholarPubMed
Lamers, J., Hartmann, M., Goldschmidt, H., et al. (2013). Psychosocial support in patients with multiple myeloma at time of diagnosis: Who wants what? Psycho-Oncology. doi: 10.1002/pon.3284. Epub ahead of print.Google Scholar
Lazarus, R.S. (1991). Emotion and adaptation. New York: Oxford University Press.Google Scholar
Lazarus, R.S. & Folkman, S. (1984). Stress, appraisal and coping. New York: Springer.Google Scholar
Maher, K. & de Vries, K. (2011). An exploration of the lived experiences of individuals with relapsed multiple myeloma. European Journal of Cancer Care, 20, 267–275.CrossRefGoogle ScholarPubMed
Merlini, G. & Palladini, G. (2012). Differential diagnosis of monoclonal gammopathy of undetermined significance. Hematology: The Education Program of the American Society of Hematology, 2012, 595–603.Google Scholar
Meyer, T.J. & Mark, M.M. (1995). Effects of psychosocial interventions with adult cancer patients: A meta-analysis of randomized experiments. Health Psychology, 14(101), 101–108.CrossRefGoogle ScholarPubMed
Miceli, T.S., Colson, K., Faiman, B.M., et al. (2011). Maintaining bone health in patients with multiple myeloma: Survivorship care plan of the International Myeloma Foundation Nurse Leadership Board. Clinical Journal of Oncology Nursing, 15, 9–23.Google Scholar
Mishel, M.H. (1984). Perceived uncertainty and stress in illness. Research in Nursing & Health, 7(3), 163–171.CrossRefGoogle ScholarPubMed
Molassiotis, A., Wilson, B., Blair, S., et al. (2011 a). Unmet supportive care needs, psychological well-being and quality of life in patients living with multiple myeloma and their partners. Psycho-Oncology, 20, 88–97.Google Scholar
Molassiotis, A., Wilson, B., Blair, S., et al. (2011 b). Living with multiple myeloma: Experiences of patients and their informal caregivers. Supportive Care in Cancer, 19, 101–111.Google Scholar
Mundy-Bosse, B.L., Thornton, L.M., Yang, H., et al. (2011). Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patients. Cell Immunology, 270(1), 80–87.Google Scholar
National Comprehensive Cancer Network (NCCN). (2010). NCCN clinical practice guidelines in oncology: Distress management. Ft. Washington, PA: NCCN Clinical Practice Guidelines.Google Scholar
National Cancer Institute (2013). PDQ®: Transitional care planning. Bethesda, MD: NCI. Available at http://cancer.gov/cancertopics/pdq/supportivecare/transitionalcare/HealthProfessional.Google Scholar
Olsen, D., McCubbin, W.I., Barnes, H., et al. (1983). Families: What makes them work? Beverly Hills: Sage Publications.Google Scholar
Potrata, B., Cavet, J., Blair, S., et al. (2011). Understanding distress and distressing experiences in patients living with multiple myeloma: An exploratory study. Psycho-Oncology, 20, 127–134.Google Scholar
Redwood, S. & Gill, P.S. (2013). Under-representation of minority ethnic groups in research: Call for action. British Journal of General Practice, 63(612), 342–343.Google Scholar
Rome, S.I., Jenkins, B.S., Lillibey, K.E., et al. (2011). Mobility and safety in the multiple myeloma survivor: Survivorship care plan of the International Myeloma Foundation Nurse Leadership Board. Clinical Journal of Oncology Nursing, 15, 41–52 CrossRefGoogle ScholarPubMed
Sherman, A.C., Simonton, S., Latif, U., et al. (2004). Physical adjustment and quality of life among multiple myeloma patients undergoing evaluation for autologous stem cell transplantation. Bone Marrow Transplantation, 33, 955–962.CrossRefGoogle ScholarPubMed
Sherman, A.C., Simonton, S., Latif, U., et al. (2009). Changes in quality-of-life adjustment among multiple myeloma patients treated with high-dose melphalan and stem cell transplantation. Biology and Bone Marrow Transplantation, 15(1), 12–20.CrossRefGoogle ScholarPubMed
Siegel, R., Naishadham, D. & Jemal, A. (2013). Cancer statistics, 2013. CA: A Cancer Journal for Clinicians, 63(1), 11–30.Google Scholar
Slovacek, L., Slovackova, B., Pavlik, V., et al. (2008). Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: A retrospective analysis. Neoplasma, 55(4), 350–355.Google Scholar
Strasser-Weippl, K. & Ludwig, H. (2008). Psychosocial QoL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma. European Journal of Haematology, 81(5), 374–379.Google Scholar
Suls, J. & Rothman, A. (2004). Evolution of the biopsychosocial model: Prospects and challenges for health psychology. Health Psychology, 23(2), 119–125.Google Scholar
Talley, R.C., McCorkle, R. & Baile, B. (2012). Caring for a loved one with cancer: Professional and family issues. In Cancer caregiving in the united states: Research, practice, and policy. McCorkle, R. et al. (eds.), pp. 1–15. New York: Springer.Google Scholar
Temel, J.S., Greer, J.A., Muzikansky, A., et al. (2010). Early palliative care for patients with metastatic non-small-cell lung cancer. The New England Journal of Medicine, 363(8), 733–742.CrossRefGoogle ScholarPubMed
Toseland, R.W., Blanchard, C.G. & McCallion, P. (1995 a). A problem-solving intervention for caregivers of cancer patients. Social Science & Medicine, 40(4), 517–528.Google Scholar
Toseland, R.W., Smith, G. & McCallion, P. (1995 b). Supporting the “family” in family caregiving. In Enabling aging families: Directions for practice and policy. Smith, G. et al. (eds.), pp. 126–154. Newbury Park, CA: Sage.Google Scholar
Weisman, A.D. (1976). The existential plight in cancer: Significance of the first 100 days. International Journal of Psychiatry in Medicine, 7(1), 1–15.Google Scholar
Zabora, J.R. & Smith, E.D. (1991). Early assessment and intervention with dysfunctional family systems. Oncology, 5(2), 31–35.Google Scholar
Zabora, J.R., Smith, E.D., Baker, F., et al. (1992). The family: The other side of BMT. Journal of Psychosocial Oncology, 10(1), 35–46.Google Scholar
Zafar, S.Y. & Abernethy, A.P. (2013). Financial toxicity, part 1: A new name for a growing problem. Oncology, 27(2), 80–81.Google Scholar